Skip to main content
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited — Investor Relations & Filings

Ticker · EMCURE ISIN · INE168P01015 LEI · 335800WYB6OIBY9EOZ42 BSE.NS Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2025-08-28 AGM Information
Country IN India
Listing BSE.NS EMCURE

About Emcure Pharmaceuticals Limited

https://www.emcure.com

Emcure Pharmaceuticals Limited is a research-driven global pharmaceutical organization engaged in the development, manufacturing, and marketing of a broad range of differentiated pharmaceutical products. The company maintains a diverse portfolio across several key therapeutic areas, including gynaecology, cardiovascular, oncology, anti-infectives, and HIV/AIDS. With a strong emphasis on research and development, Emcure operates multiple state-of-the-art manufacturing facilities and R&D centers globally. Its business model focuses on complex generics and innovative formulations, serving healthcare needs in over 70 countries. The company is recognized for its vertically integrated operations and commitment to high-quality standards, catering to both regulated and emerging markets worldwide.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed communication addressed to stock exchanges regarding the proceedings of the 44th Annual General Meeting (AGM) of Emcure Pharmaceuticals Limited held on August 28, 2025. It includes information about the meeting format (video conferencing), attendance of board members and key managerial personnel, summary of the meeting proceedings, resolutions passed including adoption of audited financial statements, dividend declaration, director appointments, and remuneration approvals. The document does not contain the full financial statements or detailed financial analysis but rather a summary of the AGM proceedings. It explicitly states it is the "Summary of Proceedings of the 44th Annual General Meeting." This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. The document length (over 10,000 characters) and content confirm it is not a brief announcement or a regulatory filing. Therefore, the correct classification is AGM Information (AGM-R).
2025-08-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Emcure Pharmaceuticals Limited for Q1 FY26. It includes opening remarks by the CEO, financial highlights by the CFO, and a Q&A session with analysts. The text references the release of quarterly financial results, discusses revenue, EBITDA, PAT, business segments, and growth outlook. The document is about 15,000 characters long, indicating it is a full transcript rather than a brief announcement. The presence of detailed financial data and management discussion confirms it is a Call Transcript (CT) rather than just an Earnings Release (ER) or Regulatory Filing (RNS).
2025-08-13 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the newspaper publication of unaudited financial results for the quarter ended June 30, 2025. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that extracts of the financial results were published in newspapers and uploaded on the company's website. The document itself does not contain the full financial statements or detailed financial analysis but is an announcement of the publication of these results. The document length is short (1882 characters), and it serves as a notification rather than the report itself. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2025-08-08 English
General Updates
Report Publication Announcement Classification · 95% confidence The document is a letter from Emcure Pharmaceuticals Limited addressed to stock exchanges and shareholders. It informs about the dispatch of a letter to members who have not registered their email addresses, providing a web-link and QR code to access the Annual Report for FY 2024-25 and the Notice of the 44th Annual General Meeting (AGM). The document references the Annual Report and AGM Notice but does not contain the actual report or financial data itself. It is essentially an announcement about the availability and dispatch of these reports and notices, including instructions for shareholders. The document length is 6430 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K) or AGM Information (AGM-R) itself.
2025-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 80% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of an earnings call for Q1 FY26. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides a link to the audio recording on the company's website. The document does not contain the transcript or detailed financial data but is an announcement about the earnings call recording availability. The document length is short (1506 characters), and it serves as a notification rather than the full transcript or financial report. Therefore, it fits best under the category of Call Transcript (CT) as it relates to the earnings call content, but since it only announces the audio recording availability and does not provide the transcript itself, the closest appropriate classification is Call Transcript (CT) with moderate confidence, as it is directly related to the earnings call content.
2025-08-07 English
Outcome of Board Meeting
Regulatory Filings
2025-08-07 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.